ProPhase Labs Inc (NASDAQ: PRPH) suffers from exceptional negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, and negative upside/downside volume developed.
Recent important negative changes in fundamentals have impacted ProPhase Labs Inc (NASDAQ: PRPH): significant quarterly sales deceleration occurred, and significant quarterly earnings deceleration occurred.
In light of these highly negative signals we are reviewing our current Overall Rating of C. We would view the shares with caution pending completion of this review in the next several days.
Current PriceTarget Research Rating
PRPH’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a modest Value Builder.
ProPhase Labs has a current Value Trend Rating of C (High Neutral). This rating combines highly consistent signals from two proprietary PTR measures of a stock’s attractiveness. ProPhase Labs has a neutral Appreciation Score of 58 and a neutral Power Rating of 58, producing the High Neutral Value Trend Rating.
Recent Price Action
ProPhase Labs Inc (NASDAQ: PRPH) stock closed at $4.77 on 6/12/24 after a large increase of 3.0%. However, this advance was accompanied by exceptionally low trading volume at 39% of normal. The stock has declined -1.6% during the last week but has been strong relative to the market over the last nine months.
Be the first to comment